Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Pascal Mäser
Identification of Antiprotozoal Steroidal Alkaloids from Holarrhena pubescens Wall. ex G. Don
Submitted: 23 January 2026 You are already at the latest version Human African Trypanosomiasis (HAT) and malaria are serious infectious diseases endemic in tropical regions, caused by protozoan parasites, and necessitating an urgent development of new antiprotozoal drugs. As part of our ongoing search for new antiprotozoal steroidal alkaloids from plants, we investigated the methanolic stem bark extract of Holarrhena pubescens (Apocynaceae). H.
Anti‐trypanosomatid and Antiplasmodial Activities of Alkaloids from Hippeastrum species
Supporting Information As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.
Antiprotozoal Aminosteroids from Pachysandra terminalis
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Biology | Free Full-Text | Phylogenetic Analysis of Pyruvate-Ferredoxin Oxidoreductase, a Redox Enzyme Involved in the Pharmacological Activation of Nitro-Based Prodrugs in Bacteria and Protozoa
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Drug Repurposing in the Chemotherapy of Infectious Diseases
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Venturicidin A affects the mitochondrial membrane potential and induces kDNA loss in Trypanosoma brucei
Abstract Neglected tropical diseases caused by trypanosomatid parasites have devastating health and economic consequences, especially in tropical areas. New drugs or new combination therapies to fight these parasites are urgently needed. Venturicidin A, a macrolide extracted from Streptomyces, inhibits the ATP synthase complex of fungi and bacteria. However, its effect on trypanosomatids is not fully understood.
Phylogenetic Analysis of Pyruvate-Ferredoxin Oxidoreductase, a Redox Enzyme Involved in the Activation of Nitro-Based Prodrugs in Bacteria and Protozoa
Preprint Article Version 2 This version is not peer-reviewed Version 1 : Received: 25 November 2023 / Approved: 27 November 2023 / Online: 28 November 2023 (01:39:45 CET) Version 2 : Received: 29 February 2024 / Approved: 1 March 2024 / Online: 1 March 2024 (07:57:55 CET) Duwor, S.; Brites, D.; Mäser, P. Phylogenetic Analysis of Pyruvate-Ferredoxin Oxidoreductase, a Redox Enzyme Involved in the Activation of Nitro-Based Prodrugs in Bacteria and Protozoa. Preprints 2023, 2023111649.
100 Years of Suramin
Minireview Natalie Wiedemar, Dennis A. Hauser, Pascal Mäser DOI: 10.1128/AAC.01168-19 ABSTRACT Suramin is 100 years old and is still being used to treat the first stage of acute human sleeping sickness, caused by Trypanosoma brucei rhodesiense. Suramin is a multifunctional molecule with a wide array of potential applications, from parasitic and viral diseases to cancer, snakebite, and autism. Suramin is also an enigmatic molecule: What are its targets? How does it get into cells in the first place?
From Magic Bullet to Magic Bomb: Reductive Bioactivation of Antiparasitic Agents
The Magic Bullet “Wir müssen chemisch zielen lernen,” Paul Ehrlich proclaimed more than 100 years ago, referring to antiparasitic chemotherapy as a magic bullet that only kills the pathogen but not its host. Ehrlich had developed his concept of chemotherapia specifica based on histological studies, having observed that some of the synthetic dyes that he was experimenting with exhibited a greater affinity to parasites than to host cells.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Pascal
Contact Pascal, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack